Success Metrics

Clinical Success Rate
100.0%

Based on 11 completed trials

Completion Rate
100%(11/11)
Active Trials
1(8%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
12
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution12 total trials
N/ANon-phased studies
12(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

11 of 11 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

12

all time

Status Distribution
Active(1)
Completed(11)

Detailed Status

Completed11
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
12
Active
1
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A12 (100.0%)

Trials by Status

completed1192%
active_not_recruiting18%

Recent Activity

1 active trials
Showing 5 of 12
active_not_recruitingnot_applicable

The ESTxENDS Trial- Electronic Nicotine Delivery Systems as an Aid for Smoking Cessation-extension of Follow-up

NCT04236791
completednot_applicable

The ESTxENDS Trial- Substudy on the Effects of Using Electronic Nicotine Delivery Systems (ENDS) on Sleep Quality.

NCT03603353
completednot_applicable

The ESTxENDS Trial- Substudy on Effects of Using Electronic Nicotine Delivery Systems (ENDS) on Olfactory Function

NCT04617444
completednot_applicable

ESTxENDS Trial-Substudy on Oxidative Stress Induced by Electronic Nicotine Delivery Systems (ENDS) Measured in Urine

NCT03612375
completednot_applicable

The ESTxENDS Trial- Substudy on the Effects of Using Electronic Nicotine Delivery Systems (ENDS) on Depression

NCT03603340
View all 12 trials

Clinical Trials (12)

Showing 12 of 12 trials
NCT04236791Not Applicable

The ESTxENDS Trial- Electronic Nicotine Delivery Systems as an Aid for Smoking Cessation-extension of Follow-up

Active Not Recruiting
NCT03603353Not Applicable

The ESTxENDS Trial- Substudy on the Effects of Using Electronic Nicotine Delivery Systems (ENDS) on Sleep Quality.

Completed
NCT04617444Not Applicable

The ESTxENDS Trial- Substudy on Effects of Using Electronic Nicotine Delivery Systems (ENDS) on Olfactory Function

Completed
NCT03612375Not Applicable

ESTxENDS Trial-Substudy on Oxidative Stress Induced by Electronic Nicotine Delivery Systems (ENDS) Measured in Urine

Completed
NCT03603340Not Applicable

The ESTxENDS Trial- Substudy on the Effects of Using Electronic Nicotine Delivery Systems (ENDS) on Depression

Completed
NCT03612453Not Applicable

ESTxENDS Trial- Substudy on Oxidative Stress Induced by Electronic Nicotine Delivery Systems (ENDS) Measured in EBC

Completed
NCT04244773Not Applicable

ESTxENDS Trial: MN Substudy - Micronuclei in Buccal Epithelium, a Surrogate Measure of Future Cancer Risk, Induced by Electronic Nicotine Delivery Systems (ENDS/Vaporizer/E-cig)

Completed
NCT03938298Not Applicable

The ESTxENDS Trial: Pulmonary Function Substudy

Completed
NCT03612544Not Applicable

The ESTxENDS Trial- Substudy on the Effect on Toxins From Using Electronic Nicotine Delivery Systems (ENDS/Vaporizer/E-cig)

Completed
NCT03632421Not Applicable

The ESTxENDS Trial- Substudy on the Effects of Using Electronic Nicotine Delivery Systems (ENDS/Vaporizer/E-cig) on Respiratory Symptoms

Completed
NCT03612336Not Applicable

The ESTxENDS Trial- Substudy on the Metabolic Effects of Using Electronic Nicotine Delivery Systems (ENDS/Vaporizer/E-cig)

Completed
NCT03589989Not Applicable

The ESTxENDS Trial- Electronic Nicotine Delivery Systems (ENDS/Vaporizer/E-cigarette) as an Aid for Smoking Cessation.

Completed

All 12 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
12